packageTositumomab

tositumomab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tositumomab is a monoclonal antibody radiopharmaceutical that was used to treat non-Hodgkin lymphoma. It was approved but has since been withdrawn from the market and is no longer in use.

Summary written by glm-5.3-flash from Wikidata Q3995913 and the WHO ATC classification; not checked by a person.

name:tositumomab
ATC codes:V10XA53
DrugBank:DB00081
Wikidata:Q3995913

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown